Search

Your search keyword '"Jensen, Gorm"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Jensen, Gorm" Remove constraint Author: "Jensen, Gorm" Publisher elsevier bv Remove constraint Publisher: elsevier bv
93 results on '"Jensen, Gorm"'

Search Results

2. Aortic Root Dimension Using Transthoracic Echocardiography: Results from the Copenhagen City Heart Study

3. The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery disease

5. Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City Heart Study

6. Normal Values and Reference Ranges for the Ratio of Transmitral Early Filling Velocity to Early Diastolic Strain Rate: The Copenhagen City Heart Study

12. CARDIAC CHARACTERISTICS OF HOSPITALIZED INFLUENZA PATIENTS: AN INTERIM ANALYSIS FROM THE FLUHEART STUDY

13. Changes in Myocardial Tissue Velocities Over a Decade: The Copenhagen City Heart Study

15. MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis

18. NORMAL AGE- AND SEX-BASED VALUES OF RIGHT VENTRICULAR FREE WALL LONGITUDINAL STRAIN BY SPECKLE-TRACKING ECHOCARDIOGRAPHY: THE COPENHAGEN CITY HEART STUDY

22. RECOVERY OF CARDIAC FUNCTION FOLLOWING COVID-19 INFECTION: ECHOVID-19 - A LONGITUDINAL COHORT STUDY

24. Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy

25. DIASTOLIC FUNCTION ASSESSED WITH SPECKLE TRACKING OVER A DECADE AND ITS PROGNOSTIC VALUE: THE COPENHAGEN CITY HEART STUDY

28. Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study

30. Is abdominal obesity at baseline influencing weight changes in observational studies and during weight loss interventions?

31. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study

32. The Reply

35. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

39. Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial

42. Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial

46. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: A prognostic study within the CLARICOR trial

50. Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease

Catalog

Books, media, physical & digital resources